Through persistent exploration, ALDH1-targeted therapies are poised to play increasingly pivotal roles across disease research domains, ultimately achieving transformative breakthroughs from bench to bedside and delivering paradigm-shifting treatment strategies for diverse pathologies, including cancer. This evidence concerns the gene ALDH1A1 and cancer.